Scribd Logo
Upload

Welcome to Scribd!

  • Presentación 1

    Uploaded by

    s_zago
    2 views3 pages

    Original Title

    Presentación1

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    2 views3 pages

    Presentación 1

    Uploaded by

    s_zago

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 3

    TRATAMIENTO

    TRATAMIENTO
    ANTIRRETROVIRAL

    2 ITIAN

    60-70% de casos
    1-2 IP consiguen cargas
    indetectables a las 48
    semanas
    O
    1 ITINN
    Basados en IRTNN

    REGÍMENES PERIFÉRICOS:
    RÉGIMEN ALTERNATIVO:
    Efavirenz + AZT + 3TC
    Efavirenz + 3TC+ d4T

    RÉGIMEN ALTERNATIVOS:
    Efavirenz + 3TC + ddI
    Efavirenz + ABC + 3TC
    Nevirapina + 3TC + (AZT o d4T o ddI)
    Efavirenz nevirapina (CD4<250 cel/ml)

    toxicidad mitocondrial
    D4T o ddI Acidosis lactica

    You might also like